Ladislav Mirossay

2.4k total citations
79 papers, 2.0k citations indexed

About

Ladislav Mirossay is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Ladislav Mirossay has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Physiology. Recurrent topics in Ladislav Mirossay's work include Synthesis and biological activity (9 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Photodynamic Therapy Research Studies (8 papers). Ladislav Mirossay is often cited by papers focused on Synthesis and biological activity (9 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Photodynamic Therapy Research Studies (8 papers). Ladislav Mirossay collaborates with scholars based in Slovakia, Czechia and France. Ladislav Mirossay's co-authors include Ján Mojžíš, Lenka Varinská, Gabriela Mojžišová, A. Miroššay, Eric Chastre, Irena Kostova, Arianna Giacomini, S. Bretti, Maria Flavia Di Renzo and Martina Olivero and has published in prestigious journals such as FEBS Letters, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Ladislav Mirossay

76 papers receiving 1.9k citations

Peers

Countries citing papers authored by Ladislav Mirossay

Since Specialization

Citations

This map shows the geographic impact of Ladislav Mirossay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ladislav Mirossay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ladislav Mirossay more than expected).

Fields of papers citing papers by Ladislav Mirossay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ladislav Mirossay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ladislav Mirossay. The network helps show where Ladislav Mirossay may publish in the future.

Co-authorship network of co-authors of Ladislav Mirossay

This figure shows the co-authorship network connecting the top 25 collaborators of Ladislav Mirossay. A scholar is included among the top collaborators of Ladislav Mirossay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ladislav Mirossay. Ladislav Mirossay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Induction of G2/M Phase Cell Cycle Arrest and Apoptosis by the Chalcone Derivative 1C in Sensitive and Resistant Ovarian Cancer Cells Is Associated with ROS Generation 2024 ·International Journal of Molecular Sciences ·(unknown), Mária Vilková, Lola Martínez, Ladislav Mirossay, Radka Michalková, Ján Mojžíš	7
2	Heat shock proteins in cancer – Known but always being rediscovered: Their perspectives in cancer immunotherapy 2023 ·Advances in Medical Sciences ·Alena Mazuráková, Zuzana Solárová, Lenka Koklesová, Martin Čaprnda, Robert Prosecký, (unknown), Denis Baranenko, Peter Kubatka, Ladislav Mirossay, (unknown), Peter Solár	7
3	Chalcones and Gastrointestinal Cancers: Experimental Evidence 2023 ·International Journal of Molecular Sciences ·Radka Michalková, Martin Kello, (unknown), (unknown), Ladislav Mirossay, Ján Mojžíš	20
4	Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence 2023 ·Biomolecules ·(unknown), Radka Michalková, Ladislav Mirossay, Gabriela Mojžišová, (unknown), (unknown), Ján Mojžíš	31
5	Jaspine B Hydrochloride-induced Apoptosis in HeLa Cells Is Associated With Disrupted Sphingolipid Metabolism and Ceramide Overload 2021 ·Anticancer Research ·(unknown), Martin Kello, (unknown), (unknown), (unknown), Peter Takáč, Miroslava Martinková, Eva Mezeiová, Ladislav Mirossay, Péter Gál, Martina Bago Pilátová	5
6	Antiproliferative effect of β-escin - an in vitro study. 2016 ·Acta Biochimica Polonica ·Gabriela Mojžišová, Martin Kello, Martina Bago Pilátová, Vladimı́ra Tomečková, Janka Vašková, Ladislav Vaško, (unknown), Ladislav Mirossay, Ján Mojžíš	21
7	MRP1 and GSTp1 expression in non-small cell lung cancer does not correlate with clinicopathological parameters: A Slovakian population study 2014 ·Acta Histochemica ·(unknown), (unknown), (unknown), Ladislav Mirossay	3
8	Brassinin and its derivatives as potential anticancer agents 2014 ·Toxicology in Vitro ·(unknown), Dávid Drutovič, Martina Bago Pilátová, Jaromír Mikeš, Mariana Budovská, Janka Vašková, Massimo Broggini, Ladislav Mirossay, Ján Mojžíš	34
9	Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. 2011 ·Medical Science Monitor ·(unknown), (unknown), (unknown), (unknown), (unknown), Ján Mojžíš, Peter Solár, (unknown), Marián Adamkov, Ladislav Mirossay	15
10	MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome 2009 ·The Pharmacogenomics Journal ·(unknown), M Wagnerová, (unknown), Viera Habalová, A Kohút, (unknown), (unknown), (unknown), Ladislav Mirossay, A. Miroššay	62
11	Flow Cytometry Analysis of Neural Differentiation Markers Expression in Human Glioblastomas May Predict Their Response to Chemotherapy 2009 ·Cellular and Molecular Neurobiology ·Vladimír Balik, (unknown), (unknown), I Šulla, Ladislav Mirossay, Marek Šarišský	27
12	Antiangiogenic effects of flavonoids and chalcones 2008 ·Pharmacological Research ·(unknown), Lenka Varinská, Gabriela Mojžišová, Irena Kostova, Ladislav Mirossay	199
13	Nucleic acid amplification technique for detection ofChlamydia trachomatis infection from clinical urogenital swabs 2007 ·Folia Microbiologica ·Erik Biroš, (unknown), (unknown), (unknown), Ján Mojžíš, (unknown), (unknown), I. Findlay, A. Miroššay, Ladislav Mirossay	1
14	Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy 2006 ·Phytomedicine ·Nikita Bobrov, (unknown), F Longauer, (unknown), Peter Fedoročko, (unknown), Pavol Miškovský, Ladislav Mirossay, (unknown)	9
15	Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing 2005 ·Phytomedicine ·(unknown), (unknown), Peter Fedoročko, Pavol Miškovský, Nikita Bobrov, F Longauer, (unknown), Ladislav Mirossay, (unknown)	13
16	Modulation of the phototoxic effect of hypericin in human leukemia CEM cell line by N-ethylmaleimide, amiloride and omeprazole 2002 ·Physiological Research ·A. Miroššay, Ladislav Mirossay, Marek Šarišský, (unknown), Ján Mojžíš, (unknown)	8
17	The effect of 5´-(N,N-dimethyl)-amiloride on cytotoxic activity of doxorubicin and vincristine in CEM cell lines 2001 ·Physiological Research ·(unknown), A. Miroššay, Ján Mojžíš, Ladislav Mirossay	4
18	The effect of quercetin on light-induced cytotoxicity of hypericin 2001 ·Physiological Research ·A. Miroššay, (unknown), Ladislav Mirossay, Marek Šarišský, Ján Mojžíš	14
19	Hypocrellin and hypericin-induced phototoxicity of HL-60 cells: apoptosis or necrosis? 2000 ·Phytomedicine ·A. Miroššay, Ján Mojžíš, Jana Tóthová, (unknown), (unknown), Ladislav Mirossay	14
20	Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages 1993 ·FEBS Letters ·(unknown), Ladislav Mirossay, Eric Chastre, (unknown), M. Lopez, Christian Gespach	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact